Synthetic peptide, and cosmetic composition or pharmaceutical composition and application thereof
US-2024352069-A1 · Oct 24, 2024 · US
US9750690B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9750690-B2 |
| Application number | US-201414478818-A |
| Country | US |
| Kind code | B2 |
| Filing date | Sep 5, 2014 |
| Priority date | Dec 3, 2009 |
| Publication date | Sep 5, 2017 |
| Grant date | Sep 5, 2017 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
An improved method for the manufacture of an oil-in-water emulsion involves circulation of emulsion components between a first container and a second container via a homogenizer and/or via a microfluidization device. Usefully, all of the emulsion components from the first container are emptied before being returned.
Opening claim text (preview).
The invention claimed is: 1. A method for a large-scale manufacture of a uniform oil-in-water emulsion, the method comprising steps of: providing a first emulsion; passing the first emulsion through a device at least two times, wherein the device operates under high pressure and high velocity sufficient to reduce the average size of oil droplets in the first emulsion so as to form a second emulsion; and, filtering the second emulsion with an asymmetric hydrophilic membrane so as to form a uniform oil-in-water emulsion, characterized in that the average oil droplet size is 220 nm or less and the number of oil droplets having a size>1.2 μm is 5×10 8 /ml or less, and wherein the uniform oil-in-water emulsion has a volume more than or equal to 50 liters. 2. The method of claim 1 , wherein the first emulsion has an average oil droplet size of 5000 nm or less, and wherein the number of oil droplets having a size>1.2 μm is 5×10 11 /ml or less. 3. The method of claim 1 , wherein the second emulsion has an average oil droplet size of 500 nm or less, and wherein the number of oil droplets having a size>1.2 μm is 5×10 10 /ml or less. 4. The method of claim 1 , wherein the device comprises an auxiliary processing module and an interaction chamber. 5. The method of claim 4 , wherein the auxiliary processing module is positioned downstream of the interaction chamber. 6. The method of claim 4 , wherein the auxiliary processing module comprises a Z-type channel. 7. The method of claim 6 , wherein the auxiliary processing module comprises a plurality of Z-type channels. 8. A method for a large-scale manufacture of a pharmaceutical composition, the method comprising steps of: providing a first emulsion; passing the first emulsion through a device at least two times, wherein the device operates under high pressure and high velocity sufficient to reduce the average size of oil droplets in the first emulsion so as to form a second emulsion; filtering the second emulsion with an asymmetric hydrophilic membrane so as to form a uniform oil-in-water emulsion, characterized in that the average oil droplet size is 220 nm or less and the number of oil droplets having a size>1.2 μm is 5×10 8 /ml or less, and wherein the uniform oil-in-water emulsion has a volume more than or equal to 50 liters; adding to the uniform oil-in-water emulsion one or more components to form a pharmaceutical composition comprising the oil-in-water emulsion. 9. The method of claim 8 , further comprising a step of sterilizing the pharmaceutical composition. 10. The method of claim 8 , wherein the pharmaceutical composition comprises an antigen. 11. The method of claim 8 , wherein the pharmaceutical composition is a vaccine. 12. The method of claim 8 , wherein the pharmaceutical composition comprises squalene. 13. The method of claim 8 , wherein the pharmaceutical composition comprises squalene, polysorbate 80 and sorbitan trioleate. 14. The method of claim 3 , wherein the first emulsion is passed through the device at least five times.
for influenza or rhinoviruses · CPC title
Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers (A61K9/0026 takes precedence) · CPC title
Emulsions, e.g. Freund's adjuvant, MF59 · CPC title
characterised by the immunostimulating additives, e.g. chemical adjuvants · CPC title
Emulsions {; Emulsion preconcentrates; Micelles (composition of emulsions A61K47/00)} · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.